What is H.C. Wainwright's price target for TPST?

H.C. Wainwright's latest stated price target for Tempest Therapeutics Inc. (TPST) is $11, from its action on Jan 22, 2026.

What is H.C. Wainwright's rating on TPST?

H.C. Wainwright rates TPST Buy, a bullish rating, as of Jan 22, 2026.

When did H.C. Wainwright last change its view on TPST?

On Jan 22, 2026, H.C. Wainwright upgrades to Buy from Neutral, price target $11.

Analyst firms · H.C. Wainwright · TPST

H.C. Wainwright TPST price target and rating history

Tempest Therapeutics Inc. (TPST) · Health Care

H.C. Wainwright rates Tempest Therapeutics Inc. (TPST) Buy with a $11 price target, as of its latest action on Jan 22, 2026. It has published 3 rating actions on TPST since July 2021, including 1 upgrade and 1 downgrade.

Current rating: Buy
Price target: $11
Median target, all firms: Too few
Actions on TPST: 3

H.C. Wainwright price target on TPST

H.C. Wainwright price target on TPST, each point a stated target, July 2021 to January 2026.

Every H.C. Wainwright rating on TPST

Jan 22, 2026
UpgradeH.C. Wainwright upgrades to Buy from Neutral, price target $11
Apr 10, 2025
DowngradeH.C. Wainwright downgrades to Neutral from Buy
Jul 13, 2021
InitiateH.C. Wainwright starts coverage at Buy, price target $51

Questions about H.C. Wainwright and TPST

What is H.C. Wainwright's price target for TPST?: H.C. Wainwright's latest stated price target for Tempest Therapeutics Inc. (TPST) is $11, from its action on Jan 22, 2026.
What is H.C. Wainwright's rating on TPST?: H.C. Wainwright rates TPST Buy, a bullish rating, as of Jan 22, 2026.
When did H.C. Wainwright last change its view on TPST?: On Jan 22, 2026, H.C. Wainwright upgrades to Buy from Neutral, price target $11.

All H.C. Wainwright ratings TPST news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.